NCT06397196 Effects of Laser Guided Cervical Proprioceptive Exercises in Patients With Cervical Radiculopathy
| NCT ID | NCT06397196 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Cervical Radiculopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2023-12-10 |
| Primary Completion | 2024-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2023-12-10 with a primary completion date of 2024-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cervical radiculopathy is a peripheral nervous system condition characterized by pathology of the cervical nerve root. Laser guided proprioceptive exercises shows positive impact in improving Joint sense error. The aim of this study is to investigate how proprioceptive exercises laser guided exercises, in addition to conventional exercises, affect cervical range of motion, pain, functional disability, and joint position sense error in patients with cervical radiculopathy. This randomized Controlled trial will be conducted at Islam central hospital, Sialkot. The sample size will consist of 52 participants. Participants who meet the inclusion criteria will be taken through a non-probability convenience sampling technique. 26 participants will be assigned to the group A and 26 participants to group B. Group A will receive laser guided exercises along with routine physical therapy whereas Group B will only receive routine physical therapy. All participants will receive a 50-minute session daily, 3 times a week for 3 weeks. Data will be collected using various assessment tools, Numeric pain rating scale will be use to assess the Pain, Bubble in-clinometer to assess Cervical range of motion, Laser tracker to assess Joint sense position error and Neck disability Index to assess functional disability. Pre-intervention assessment will be conducted before starting the treatment protocol and post assessment after 4 weeks of treatment.
Eligibility Criteria
Inclusion Criteria: * Age 35 to 55 years. * Both Genders. * Patients with positive Spurling test . * Patients with positive Distraction test . * Radicular Symptoms in Upper Extremity. (Pain, tingling or numbness in fingers and hand, weakness in arms, shoulders and hand) * Numeric pain rate scale 3 to 7 (moderate) Exclusion Criteria: * Patients with cervical surgery. * Congenital anomalies involving the cervical spine. * Any neurological disease (e.g, cerebellar disorders, multiple sclerosis, Parkinson's disease, syringomyelia) * Specific cause of cervical pain with previous medical diagnosis (e.g., traumatic, rheumatic or systemic pathology) * Known or suspected vestibular pathology, dizziness, sensory nerve pathways or vascular disorders (e.g., migraine, hypertension) * Patients suffering from Vertigo , and Vertebro basilar insufficiency (VBI).
Contact & Investigator
Sabiha Arshad, M.phill
PRINCIPAL INVESTIGATOR
Riphah Intenational University
Frequently Asked Questions
Who can join the NCT06397196 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 55 Years, studying Cervical Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06397196 currently recruiting?
Yes, NCT06397196 is actively recruiting participants. Contact the research team at iqbal.tariq@riphah.edu.pk for enrollment information.
Where is the NCT06397196 trial being conducted?
This trial is being conducted at Sialkot, Pakistan.
Who is sponsoring the NCT06397196 clinical trial?
NCT06397196 is sponsored by Riphah International University. The principal investigator is Sabiha Arshad, M.phill at Riphah Intenational University. The trial plans to enroll 52 participants.